Neha Verma, MD

Dr. Neha Verma serves as the Medical Director of the Internal and Hospital Medicine Department and is an Associate Member at both Moffitt Cancer Center and the USF Morsani College of Medicine. She graduated with honors in Biochemistry from Case Western Reserve University and earned her medical degree before completing her Internal Medicine residency at Mount Sinai Hospital in Chicago. Prior to joining Moffitt, she worked as a hospitalist at Northwestern Memorial Feinberg Hospital in Chicago, IL. Dr. Verma is passionate about medical education and teaches a wide range of students and trainees. In her first year at Moffitt, she was honored with the Golden Apple Recognition Award by USF Internal Medicine residents. Her research focuses on immune-related adverse events from immunotherapy. She founded Moffitt’s Immunotherapy Toxicity (I-TOX) service and serves as Principal Investigator on multiple studies, including “Neurologic Complications of Immune Checkpoint Inhibitors” and “Evaluation of Patient Outcomes with Implementation of an Immunotherapy Toxicity Service (I-TOX).” She is also first author of a book chapter on Paraneoplastic Syndromes and was profiled in Women in Oncology at Moffitt for her contributions to the field. Outside of work, Dr. Verma is a passionate advocate of women in medicine and the founder of the “Tampa Female Physicians” group, actively engages in community service, and regularly speaks with members of the American Medical Women's Association (AMWA) through USF to mentor and inspire the next generation of female physicians.

Education & Training

Residency:

• Mount Sinai Hospital - Internal Medicine

Medical School:

• Ross University School of Medicine - MD

• Baron M, Amisha F, Kaur K, Verma N. Nivolumab-Induced Warm Autoimmune Hemolytic Anemia and Pancytopenia. Cureus. 2025 Sep.17(9):e92951. Pubmedid: 41141080. Pmcid: PMC12547619.
• Lee G, Benyahia S, Syed M, Thakkar H, Reich R, Lochner J, Isenalumhe L, Hembree T, Verma N, Abdallah E. QIM25-218: Improving Quality Outcomes Through a Hospitalist-Driven Malignant Hematology Service. J Natl Compr Canc Ne. 2025 Mar.23(3.5). Pubmedid: 40154296.
• Afiat TN, Jalali S, McCain C, Jayson A, Thakkar H, Eaton K, Hembree TN, Verma N. An Atypical Presentation of Sweet's Syndrome in a Patient With Neutropenia: A Case Report. Cureus. 2025 Feb.17(2):e79023. Pubmedid: 40099100. Pmcid: PMC11911253.
• Boldig C, Warman M, Chavez J, Dubey D, Abukhdeir A, Iacono D, Verma N, Jaffer M, Teeling A, DeLuca K, Riedel H, Mokhtari S. A case of chronic lymphocytic leukemia with a paraneoplastic neurologic syndrome and leptomeningeal disease. Discov Med (Cham). 2024 Nov.1(120).
• Jalali S, Bhatt H, Thakkar K, Julka R, Pasikhova Y, Verma N. Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report. In Vivo. 2024 Nov.38(6):3106-3111. Pubmedid: 39477427. Pmcid: PMC11535902.
• Verma N, Jaffer MH, Kolli AS, Mokhtari S. Updates in the Management of Paraneoplastic Syndrome. Semin Neurol. 2024 Feb.44(1):36-46. Pubmedid: 38183975.
• Poovathukaran Babu A, Kis B, Patrick J, Verma N. Partial Splenic Artery Embolization in the Management of Acute Immune Thrombocytopenia Refractory to Medical Treatment. Ann Intern Med Clin Cases. 2023 Mar.
• Patrick J, Babu A, Verma N. An Unusual Presentation of Cryoglobulinemia in a Patient With Undiagnosed Sjögren's Syndrome and Treated Marginal Zone Lymphoma. Cureus. 2022 Dec.14(12):e32730. Pubmedid: 36686139. Pmcid: PMC9851851.
• Hembree T, Theou O, Thirlwell S, Reich RR, Cao B, Sehovic M, Syed M, Verma N, Nguyen TC, Keerty D, Wesolow J, Koverzhenko V, Extermann M, Huang J, Ramsakal A. A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study. Cancer Med. 2021 Sep.10(17):5765-5774. Pubmedid: 34350715. Pmcid: PMC8419777.
• Seok K, Hallanger-Johnson J, Holmstrom B, Hembree T, Sharda E, Ramsakal A, Verma N. Literally Malignant Hypertension. SN Compr Clin Med. 2021 May.3:1960-1964.
• Verma N, Jaffer M, Pina Y, Peguero E, Mokhtari S. Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 2021 Jul.13(7):e16337. Pubmedid: 34395120. Pmcid: PMC8357079.
• Shareef N, Verma N, Syed M. Strongyloides hyperinfection syndrome. Postgrad Med J. 2021 Jan. Pubmedid: 33452142.
• Jaffer M, Chung M, Sharda E, Ramsakal A, Peguero E, Verma N, Mokhtari S. Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. Clin Med Insights Oncol. 2020 Dec.14. Pubmedid: 33447124. Pmcid: PMC7780164.
• Chung M, Jaffer M, Verma N, Mokhtari S, Ramsakal A, Peguero E. Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange. J Neurol. 2020 Apr.267(4):1023-1025. Pubmedid: 31832829.
• Vanosdoll M, Ng N, Ho A, Wallingford A, Xu S, Matin SB, Verma N, Farzin A, Golden WC, Yazdi Y, Waiswa P, Labrique A, Acharya S. A Novel Mobile Health Tool for Home-Based Identification of Neonatal Illness in Uganda: Formative Usability Study. JMIR Mhealth Uhealth. 2019 Aug.7(8):e14540. Pubmedid: 31418428. Pmcid: PMC6714500.
• Malhotra G, Verma N, Iliescu M. Propofol Infusion Syndrome—A Rare Complication of Propofol Use!. Am J Respir Crit Care Med. 2016.
• Babu RJ, Chatterjee A, Fulzele S, Verma N, Singh M. Effect of Low-Level Prolonged Exposures of JP8 on the Biomarker in the Skin of Wistar Rats. Toxicologist. 2005.

Voted top doctor in Internal Medicine in Tampa Magazine's Top Doctors 2025.